RARA and acute promyelocytic leukemia: Retinoids have found a clinical role in the treatment of acute promyelocytic leukemia (APL) (M3 subtype of acute myeloid leukemia), which is associated with translocations involving RARA and which undergo maturation in response to ATRA [21,22].